Caladrius Biosciences, Inc.
(NASDAQ : CLBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Wholesale Distributors
symbolcompany%chnglast%shortavg$volume
GWWW.W. Grainger, Inc.
3.24%229.8911.6%$184.33m
FASTFastenal Company
1.41%53.287.0%$126.62m
HDSHD Supply Holdings, Inc.
1.45%38.391.7%$103.94m
GPCGenuine Parts Company
0.54%91.971.8%$77.25m
BECNBeacon Roofing Supply, Inc.
2.56%61.642.5%$51.87m
MSMMSC Industrial Direct Co., Inc. Class A
3.06%91.714.1%$42.65m
POOLPool Corporation
1.90%130.152.1%$29.63m
UNVRUnivar, Inc.
7.23%30.871.3%$22.62m
MRCMRC Global Inc.
1.59%15.975.0%$18.23m
WCCWESCO International, Inc.
2.61%64.902.9%$17.91m
MARKRemark Media, Inc.
0.77%7.810.9%$16.73m
DNOWNOW Inc
0.00%10.286.1%$14.06m
INTWorld Fuel Services Corporation
2.24%27.823.6%$13.48m
AITApplied Industrial Technologies, Inc.
2.94%63.101.2%$11.86m
SUNSunoco LP
-1.22%28.773.5%$10.13m

Company Profile

Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. The company was founded in September 1980 and is headquartered in New York, NY.